Manolete Partners Plc (LON:MANO – Get Free Report)’s share price reached a new 52-week low during trading on Tuesday . The company traded as low as GBX 54.17 and last traded at GBX 56, with a volume of 149922 shares traded. The stock had previously closed at GBX 56.50.
Analysts Set New Price Targets
Separately, Canaccord Genuity Group reduced their target price on shares of Manolete Partners from GBX 172 to GBX 130 and set a “buy” rating on the stock in a report on Wednesday, November 19th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Manolete Partners currently has a consensus rating of “Buy” and a consensus price target of GBX 130.
View Our Latest Research Report on MANO
Manolete Partners Stock Performance
Manolete Partners (LON:MANO – Get Free Report) last issued its quarterly earnings results on Wednesday, November 19th. The company reported GBX (1.09) earnings per share (EPS) for the quarter. Manolete Partners had a return on equity of 109.76% and a net margin of 180.12%. Research analysts forecast that Manolete Partners Plc will post 4.2845258 earnings per share for the current year.
Insider Transactions at Manolete Partners
In related news, insider Leigh of Hurley sold 65,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of GBX 71, for a total value of £46,150. Insiders own 11.70% of the company’s stock.
About Manolete Partners
Manolete Partners Plc is the UK’s leading insolvency litigation financing company which was founded in 2009 by its Chief Executive, Steven Cooklin, a UK Chartered Accountant.
Manolete finances the pursuit of claims through litigation and alternative dispute resolution to produce optimal returns for the creditors of insolvent companies. The Company has invested in over 1,300 specialist UK insolvency cases and has recovered over £120m for Creditor Estates with an average case duration of just 12 months per case.
Featured Stories
- Five stocks we like better than Manolete Partners
- Hit Your Retirement “Freedom Number” (Without $1 Million)
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
- Trump’s new AI budget just passed — one stock could soar
- A Message From An Ex-CIA Officer About Trump
Receive News & Ratings for Manolete Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manolete Partners and related companies with MarketBeat.com's FREE daily email newsletter.
